Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan in Intermittent Claudication
NCT01890135Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Jun 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zibotentan in intermittent claudication (IC), sponsored by University of Virginia. Started Jun 2013; status: completed.
02
Drugs
zibotentan
03
Conditions
intermittent claudication (IC)
Beyond the preview
Go deeper on NCT01890135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01890135.